Axaton Fetal ECG
- The world's first non-invasive fetal ECG Monitor
Prevention from the first beat
Axalton Fetal ECG is the world’s first easy-to-use, non-invasive real-time fetal ECG measurement system that can detect the mother's and the fetus' electrical and mechanical heart functions at the same time.
Real time results for fast diagnosis and peace of mind
High quality signals
Evaluation is accurate and easy for the algorithm to detect even the smallest abnormalities
Lovable, friendly, human-centered design. The Axalton Fetal ECG looks more like a gadget, rather than a medical device.
Non-invasive, Safe Examinations
Fetal monitoring is important to diagnose abnormalities that can occur during pregnancy. If detected in time, these might be resolved before further complications.
The fetal signal volume is only one-sixth of the mother's and so far it could be measured only by a CTG (cardiotocography) which is in current clinical practice obtained via either an invasive scalp electrode, or via non-invasive Doppler ultrasound technology that might be inaccurate and can suffer from loss of signal, in particular in women with high body mass, during motion, or in preterm pregnancies.
Axalton Fetal ECG is able to detect very small mV signals, which is a huge step towards fetal health and prevention.
Comfort in Heartbeats
Axalton Fetal ECG is consciously designed to be used easily in various settings. It is light, uncomplicated and looks like a friendly, wearable gadget. It is smooth, rounded, like a pebble and comes in pleasant, appealing colours.
It can be easily secured on clothes and it is comfortable to wear even for longer periods. Thanks to its small size it is easy to carry and can be applied an operated quickly.
In Development
Axalton Fetal ECG is currently in development with the involvement of medical advisors. As Axalton Med Tech`s other projects, we are aiming to create an advanced clinical and at-home diagnostic device that increases both the doctors' and the patients' comfort by the mobility of the device, with the option of automated diagnostics and real-time monitoring.
A new market is born
The current size of the global fetal monitoring market is around 2.9 billion USD and estimated to double until 2030.
Although the above statistics only considered at technologies such as CTG, heart sound and scalp fetal ECG, they still give a clear and strong indication of the projected growth of the fetal monitoring market and the demand for new, less invasive technological solutions.
We believe that we will quickly gain a large market share with its genuinely innovative technology, through collaboration with reputable hospitals and renowned experts.
Hardware
Technological novelties:
The first completely non-invasive measurement system for fetal ECG
Can measure the maternal and fetal ECG signals in real time, simultaneously relaying results to a Bluetooth device.
Compact size
Professional significance:
Uncomplicated application compared to existing procedures
Easy to carry
Quicker assessment
Software
Technological novelties:
Patented fetal ECG measurement procedure
It enables noise-free measurement results
The fetal heart sound and ECG can be displayed simultaneously
Complex determination of the PQRST signal from the measured signals
Manual and automatic annotation procedures
Uploading data to a cloud service
Professional significance:
Established database that can be used for further research and enables the implementation of continuous data analysis and abnormality procedures
